Hepatitis Testing/Diagnosis Market - Trends Forecast Till 2028

Market Overview

The global hepatitis testing market is projected to reach USD 2.8 billion in 2021, at a CAGR of 6.7% during the forecast period.

The term Hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. However, hepatitis is often caused due to viral infection. The most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C.

The high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis are some of the factors that have supported long-term expansion for Hepatitis Testing/Diagnosis Market.

The COVID-19 outbreak had a negative impact on the hepatitis testing market due to decreasing patient visits to hospitals. The pandemic has put significant strain on healthcare systems. Healthcare institutes and providers were instructed to stop performing elective surgical procedures and medical examinations to slow the spread of the disease and conserve healthcare resources for COVID-19 patients.

Regional Analysis

In 2020, North America dominates the global market, and this trend is expected to continue during the forecast period. The large share and high growth of this region can be attributed to the rising prevalence of hepatitis and increased research and clinical trials for hepatitis testing in the US.

Insights are provided for each region and major countries within the regions

Competitive Landscape

Key Players

• Abbott Laboratories
• Danaher Corporation
• BioMerieux SA
• Bio-Rad Laboratories Inc
• Diasorin S.p.A
• F. Hoffmann-La Roche AG
• Hologic Inc
• MedMira Inc
• Qaigen Inc
• Siemens Healthineers

Recent Developments

• In 2021, Abbott received FDA Emergency Use Authorization (EUA) for the Alinity m Resp-4-Plex assay.
• In 2021, F.Hoffmann-La Roche Ltd. acquired GenMark Diagnostics (US) which aimed at adding more products to Roche’s molecular diagnostics portfolio and the global distribution of products offered by GenMark Diagnostics.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Hepatitis Testing/Diagnosis Market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope